29th week of 2009 patent applcation highlights part 15 |
Patent application number | Title | Published |
20090180967 | ULTRSONICALLY ACTIVE MICROPARTICLES AND METHOD OF USE - An ultrasonically active microparticle is taught that includes a porous interior particle having hydrophobic pores, a gas in the hydrophobic pores and a hydrophilic exterior shell surrounding the interior particle forming an ultrasonically active microparticle and allowing the microparticle to be suspended in an aqueous solution. | 2009-07-16 |
20090180968 | Metal Coordination Complexes Of Volatile Drugs - The present disclosure provides a drug delivery device comprising a housing defining an airway, wherein the airway comprises at least one air inlet and a mouthpiece having at least one air outlet, at least one heated metal substrate disposed within the airway, at least one drug disposed on the at least one heated metal substrate. Drugs that can be complexed with metals or metal salts and could be deposited as thin films on heated metal substrate for generating thermal condensation aerosols are particularly suited. The metal substrate could be electrically or chemically heated. Further, the chemically heated metal source could be activated by an igniter that generates heat or spark. | 2009-07-16 |
20090180969 | PHARMACEUTICAL FORMULATION COMPRISING AN ANTICHOLINERGIC DRUG - Pharmaceutical formulations suitable to be administered by pressurised metered dose inhalers (pMDIs) comprising a salt of 3-[[[(3-fluorophenyl)[(3,4,5-trifluoro phenyl)methyl]amino]carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane are effective for the prevention and/or treatment of an obstructive airways disease. | 2009-07-16 |
20090180970 | FOAMABLE COMPOSITION COMBINING A POLAR SOLVENT AND A HYDROPHOBIC CARRIER - The present invention relates to a foamable vehicle or cosmetic or pharmaceutical composition, comprising: (1) an organic carrier, at a concentration of 10% to 70% by weight, wherein said organic carrier concurrently comprises: (i) at least one hydrophobic organic carrier, and (ii) at least one polar solvent; (2) at least one surface-active agent; (3) water; and (4) at least one liquefied or compressed gas propellant at a concentration of 3% to 25% by weight of the total composition. | 2009-07-16 |
20090180971 | Method for the prevention and/or activation of defense mechanisms in the human body against conditions, disorders or diseases relating to the presence of free radicals, such as: environmental pollution, aging or smoking - The invention provides a method for the prevention and/or activation of defense mechanisms in the human body against conditions, disorders or diseases relating to the presence of free radicals, such as; environmental pollution, aging or smoking by rising the administration to a mammal, namely a human being, of an effective amount of a phytonutrient-and-citric-based edible dosage, during or after tobacco consumption and which is intended to prevent pathologies, conditions, disorders or diseases relating to the presence of free radicals in the human body. Likewise, the therapeutic method of the invention enables activation of defense mechanisms in the human body to reduce conditions, disorders or diseases relating to the presence of free radicals in the body. | 2009-07-16 |
20090180972 | COMPOSITIONS OF OXO-TERPENE DERIVATIVES AND PROCESS FOR PREPARING THE SAME - Described is to a process for augmenting, enhancing, modifying, or imparting a berry or citrus aroma or taste to a foodstuff or a beverage comprising the step of adding to a foodstuff or a beverage an aroma or taste augmenting, enhancing, modifying, or imparting quantity of at least an oxo-terpene carbinol, a carbinyl C | 2009-07-16 |
20090180983 | BICYCLIC, C5-SUBSTITUTED PROLINE DERIVATIVES AS INHIBITORS OF THE HEPATITIS C VIRUS NS3 PROTEASE - The present invention relates to compounds of Formula I or pharmaceutically acceptable salts, esters, or prodrugs thereof: | 2009-07-16 |
20090180984 | MACROCYCLIC OXIMYL HEPATITIS C SERINE PROTEASE INHIBITORS - The present invention relates to compounds of Formula I, or pharmaceutically acceptable salts, esters, or prodrugs thereof: | 2009-07-16 |
20090180985 | BRIDGED CARBOCYCLIC OXIME HEPATITIS C VIRUS SERINE PROTEASE INHIBITORS - The present invention discloses compounds of formula I, or pharmaceutically acceptable salts, esters, or prodrugs thereof: | 2009-07-16 |
20090180986 | TREATING UNWANTED OCULAR CONDITIONS USING AN ASCOMYCIN MACROLACTAM - The present invention provides compositions and uses of an ascomycin macrolactam for the treatment of an unwanted ocular condition occurring in a patient undergoing treatment with a therapeutically active agent for the treatment of cancer. | 2009-07-16 |
20090180987 | Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders - Methods for detecting a microorganism or cell in a subject and methods for detecting, imaging or diagnosing a site, disease, disorder or condition in a subject using microorganisms or cells and methods that microorganisms or cells for treating a disease, disorder or condition are provided. Sites, diseases and disorders include sites of cell proliferation, proliferative conditions, neoplasms, tumors, neoplastic disease, wounds and inflammation. Also provided are microorganisms and cells for use in the methods and compositions, combinations and kits, including diagnostic and pharmaceutical compositions, containing a microorganism or cell. | 2009-07-16 |
20090180988 | Id-1 and Id-2 Genes and Products as Therapeutic Targets for Treatment of Breast Cancer and Other Types of Carcinoma - A method for treatment and amelioration of breast, cervical, ovarian, endometrial, squamous cells, prostate cancer and melanoma in a patient comprising targeting Id-1 or Id-2 gene expression with a delivery vehicle comprising a product which modulates Id-1 or Id-2 expression. | 2009-07-16 |
20090180989 | Compositions and methods for delivering nucleotide sequences to vertebrates - The invention includes methods of producing viral particles which include introducing into avian cells a nucleotide sequence encoding a replication deficient retroviral vector and introducing into the avian cells nucleotide sequence encoding products required for replication of the replication deficient retroviral vector, harvesting the viral particles and can include administering the viral particles to vertebrate cells. | 2009-07-16 |
20090180990 | Composition for maintaining healthy kidney function - The present invention provides a composition comprising prebiotic and probiotic components and is used to reduce elevated levels of nitrogenous waste products and to promote a healthy bowel microenvironment. | 2009-07-16 |
20090180991 | METHOD FOR TREATING INFLAMMATION ASSOCIATED WITH AMYLOID DEPOSITS AND BRAIN INFLAMMATION INVOLVING ACTIVATED MICROGLIA - Filamentous bacteriophage which does not display an antibody or a non-filamentous bacteriophage antigen on its surface is used to inhibit or treat brain inflammation associated with amyloid deposits and/or involving activated microglia, to inhibit the formation of amyloid deposits, and to disaggregate pre-formed amyloid deposits. | 2009-07-16 |
20090180992 | COMPOSITIONS AND METHODS FOR THE TREATMENT, MITIGATION AND REMEDIATION OF BIOCORROSION - A method of reducing biocorrosion or biofilm blockage in by identifying a target suspected of comprising one or more biocorrosive organisms and delivering to the target suspected of comprising the biocorrosive organisms an effective amount of a composition comprising an infective virulent viral panel sufficient to reduce the amount of biocorrosive organisms at the target. | 2009-07-16 |
20090181003 | Regulation of S6 Kinsase Protein Activity and Related Methods - The invention encompasses agents and their methods of use for modulating the activity of kinases by effecting their acetylation or their binding to nucleic acids. The invention thus encompasses the modulation of S6 kinase by effecting its acetylation by p300. The invention further encompasses the modulation of S6 kinase 2 by affecting its binding to DNA. | 2009-07-16 |
20090181004 | MODIFIED BETA-LACTAMASE AND METHOD FOR ITS PREPARATION - The invention relates to targeted post translational modifi-cation of metallo-beta-lactamase by truncation and inser-tion of a dipeptide at the amino terminal end to reduce amino terminal heterogeneity in a recombinant DNA pro-duction system. A protein K-T-E-ΔBL is expressed, and modified by host proteases to E-ΔBL. Appropriate nucleotide molecules, vectors and hosts are also de-scribed. E-ΔBL is useful in a pharmaceutical composition for treating antibiotic induced adverse effects in the intes-tine of patients treated with beta-lactam antibiotics. | 2009-07-16 |
20090181005 | NUCLEIC ACID ENCODING PROTEINS INVOLVED IN PROTEIN DEGRADATION, PRODUCTS AND METHODS RELATED THERETO - In accordance with the present invention, there are provided novel Siah-Mediated-Degradation-Proteins (SMDPS) and/or SCF-Complex Proteins (SCPs). Nucleic acid sequences encoding such proteins and assays employing same are also disclosed. The invention SMDPs and/or SCPs can be employed in a variety of ways, for example, for the production of anti-SMDP and/or SCP antibodies thereto, in therapeutic compositions, and methods employing such proteins and/or antibodies for drug screening, functional genomics and other applications. Also provided are transgenic non-human mammals that express the invention protein. Also provided are compositions and methods for targeting the destruction of selected polypeptides in eukaryotic cells based on the ubiquitin-independent mechanism by which ornithine decarboxylase is degraded by the 26S proteasome. | 2009-07-16 |
20090181006 | METHODS FOR DIAGNOSING AND TREATING CEREBROVASCULAR EVENTS BASED ON NR2 PEPTIDES - Methods and kits for diagnosing and treating cerebrovascular events, and for defining the time and anatomical location of an event, are provided based on the detection and quantification of bound or total and unbound NR2 peptides in biological fluids. The methods are optionally performed in conjunction with neurological scoring and neuroimaging, and are directed to risk assessment, prognosis, diagnosis and treatment of TIA and stroke on an emergency basis in the emergency room. | 2009-07-16 |
20090181007 | CULTURE MEDIUM AND PHARMACEUTICAL COMPOSITION FOR REGENERATING CARTILAGE TISSUE, A METHOD, USES AND PRODUCTS RELATED THERETO - A composition for in vitro use as a culture medium or in vivo use as a pharmaceutical composition or a medical device, capable of accelerating the differentiation of stem cells into cells with a chondrocytic phenotype and of restoring the original trophism of chondrocytes, is described. The composition comprises, in combination, at least one proteolytic enzyme, at least one growth factor and at least one from a sugar, an amino acid, a vitamin factor, a vitamin, a nucleotide and a nucleoside, in a physiologically acceptable carrier or diluent. A method of differentiating stem cells in cells having a chondrocytic phenotype, the cells obtained by the method and their uses, for example in human or animal cell therapy, for example by CBMP (Cellular Based Medicinal products) are also described. | 2009-07-16 |
20090181008 | METHODS OF TREATING ALZHEIMER'S DISEASE - The invention provides biomarkers that are modulated in Alzheimer's disease including IL-1α, PDGF-BB, TNF-α, M-CSF, G-CSF, GNDF, eotaxin 2, MCP-3, PARC, AgRP, MSP-α, and BTC. Described are methods for preventing, treating, alleviating symptoms of, or delaying the development of Alzheimer's Disease (AD) in an individual diagnosed with Alzheimer's Disease or at risk for developing the disease by modulating the biological activity of, or the levels of any one or more of these AD-associated biomarkers. Modulation of biomarker levels by administration of biomarker proteins, biologically active fragments thereof, agonists, antagonists and antibodies are provided. | 2009-07-16 |
20090181009 | ANTIBODIES TO NTB-A - Anti-NTB-A antibodies and antigen-binding fragments thereof, as well as pharmaceutical compositions comprising such antibodies and antigen-binding fragments are described. Also described are methods of using such antibodies and antigen-binding regions to bind NTB-A and treat diseases, such as hematologic malignancies, which are characterized by expression of NTB-A. | 2009-07-16 |
20090181010 | Arginase II: a target for the prevention of atherosclerosis - The instant invention provides methods and compositions for the treatment of. atherosclerotic disease. Specifically, the invention provides methods and compositions for modulating the activity of Arginase II, the production of Arginase II or the amount of free Arginase II for the treatment of atherosclerotic disease. | 2009-07-16 |
20090181011 | Compounds, Compositions and Methods for the Endocytic Presentation of Immunosuppressive Factors - Immunomodulating agents comprising at least one Fc receptor ligand and at least one immunosuppressive factor are provided as are methods for their manufacture and use. The immunomodulating agents may be in the form of polypeptides or chimeric antibodies and preferably incorporate an immunosuppressive factor comprising a T cell receptor antagonist. The compounds and compositions of the invention may be used to selectively suppress the immune system to treat symptoms associated with immune disorders such as allergies, transplanted tissue rejection and autoimmune disorders including lupus, rheumatoid arthritis and multiple sclerosis. | 2009-07-16 |
20090181012 | METHOD FOR DETECTING REGULATORY T CELLS USING EXPRESSION OF FOLATE RECEPTOR 4 AS INDICATOR, METHOD FOR TREATING DISEASES USING THE DETECTION METHOD, PHARMACEUTICAL COMPOSITION FOR IMMUNOSTIMULATION, AND METHOD FOR TREATING DISEASES USING THE COMPOSTION - An object of the present invention is to provide a technique to distinguish between T | 2009-07-16 |
20090181023 | Nogo-a binding with enhanced affinity and pharmaceutical use thereof - The present invention provides a binding molecule which is capable of binding to the human NogoA polypeptide or human NiG or human NiG-D20 or human NogoA_342-357 with a dissociation constant <1000 nM, a polynucleotide encoding such binding molecule; an expression vector comprising said polynucleotide; an expression system comprising a polynucleotide capable of producing a binding molecule; an isolated host cell which comprises an expression system as defined above; the use of such binding molecule as a pharmaceutical, especially in the treatment of nerve repair; a pharmaceutical composition comprising said binding molecule; and a method of treatment of diseases associated with nerve repair | 2009-07-16 |
20090181024 | NOVEL COMPOSITION AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES - The present invention relates to compositions containing a novel protein and methods of using those compositions for the diagnosis and treatment of immune related diseases. | 2009-07-16 |
20090181025 | T Cell Adhesion Molecule and Antibody Thereto - An object of the present invention is to provide a T cell adhesion molecule that is expressed on a dendritic cell. According to the present invention, there is provided a protein comprising the amino acid sequence of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID NO: 10 or SEQ ID NO: 12. | 2009-07-16 |
20090181026 | Tomoregulin-2-antibody compositions and methods for the diagnosis and treatment of Alzheimer's disease - The present invention is directed to methods which exploit the discovery of tomoregulin-2 (TR2) in amyloid plaques in Alzheimer's disease using TR2-sepcific antibodies; methods and compositions comprising TR2-specific antibodies for the diagnosis and treatment of Alzheimer's disease; methods and compositions comprising immunizing TR2 peptides to induce an immune response, thereby reducing/inhibiting plaque formation; and methods and compositions comprising enzyme inhibitors to blocking the enzymatic release of TR2 ectodomain from the cell surface or inhibit TR2 protein translation by RNA interference technology. | 2009-07-16 |
20090181027 | Anti-IL-12/23p40 Antibodies, Epitopes, Formulations, Compositions, Methods and Uses - An anti-IL-12/23p40 antibody that binds to a portion of the IL-12 or IL-23 protein corresponding to the p40 subunit of IL-12 or IL-23, including compositions, formulations, and methods of administration have applications in diagnostic and/or therapeutic uses and devices. | 2009-07-16 |
20090181028 | B-CELL EPITOPE PEPTIDES OF HSP 65, NOVEL AMINO ACID SEQUENCES, DNA ENCODING THE AMINO ACID SEQUENCES OF SAID PEPTIDES, ANTIBODIES DIRECTED AGAINST SAID PEPTIDES AND DIFFERENT USES THEREOF IN THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES - B-cell epitope peptides of HSP 65, particularly the peptides comprising the amino acid sequence substantially as denoted by SEQ ID: NOs. 1-5 and their biologically functional homologues and derivatives thereof. Also included are polyclonal and monoclonal antibodies directed against them and their compositions for passive immunization against inflammatory and autoimmune diseases and in the treatment of inflammatory and autoimmune diseases. Also encompassed are diagnostic uses of these antibodies, for identifying people at risk of developing arthritis or diabetes, and a method of monitoring progress of the disease conditions and disease prognosis. | 2009-07-16 |
20090181029 | Methods for treating interleukin-6 related diseases - A pharmaceutical composition for the treatment of interleukin-6 (IL-6) related diseases, comprising an interleukin-6 antagonist (IL-6 antagonist) and immunosuppressants. The IL-6 antagonist is preferably an antibody to an interleukin-6 receptor (IL-6R). | 2009-07-16 |
20090181030 | USE OF A PREPARATION BASED ON AN ANTIBODY DIRECTED AGAINST A TUMOR-ASSOCIATED GLYCOSYLATION - The invention relates to the use of a preparation based on an antibody directed against a tumor-associated glycosylation for preparing a medicament for the prophylactic and/or therapeutic treatment for the reduction or inhibition, respectively, of the growth of tumor cells in a cancer patient, as well as to a pharmaceutical preparation containing an antibody directed against a tumor-associated glycosylation. Moreover, the invention relates to a preparation for pharmaceutical and/or diagnostic use, a diagnostic method and an agent for determining the risk of metastasis formation in a cancer patient, as well as a method of producing a preparation based on a body fluid or tissue, in each case using the antibody directed against a tumor-associated glycosylation. | 2009-07-16 |
20090181031 | Antibodies to bufadienolides prevent inhibition of Na/K ATPase and prolong survival in shock - The present invention relates to compositions and methods of use thereof for treatment of clinical conditions manifested from and/or exacerbated by a decrease or an inhibition of Na/K ATPase activity. The invention relates to composition comprises monoclonal or polyclonal antibodies to bufalin and/or bufalin sulfate, or vaccination against bufalin and/or bufalin sulfate, which prevents or attenuates inhibition of Na/K ATPase activity thereby attenuating the adverse physiological effects of bufalin and/or bufalin sulfate inhibition. The invention also relates to methods of treating hemorrhagic, septic shock, cardiogenic shock, shock resulting from physical trauma, diabetes, mental depression, bipolar disorder and schizophrenia comprising administering a therapeutically effective amount of an bufalin monoclonal or polyclonal antibody. | 2009-07-16 |
20090181032 | Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof - The invention relates to the discovery of novel soluble neutral active Hyaluronidase Glycoproteins (sHASEGP's), methods of manufacture, and their use to facilitate administration of other molecules or to alleviate glycosaminoglycan associated pathologies. Minimally active polypeptide domains of the soluble, neutral active sHASEGP domains are described that include asparagine-linked sugar moieties required for a functional neutral active hyaluronidase domain. Included are modified amino-terminal leader peptides that enhance secretion of sHASEGP. The invention further comprises sialated and pegylated forms of a recombinant sHASEGP to enhance stability and serum pharmacokinetics over naturally occurring slaughterhouse enzymes. Further described are suitable formulations of a substantially purified recombinant sHASEGP glycoprotein derived from a eukaryotic cell that generate the proper glycosylation required for its optimal activity. | 2009-07-16 |
20090181043 | Method for Producing Human Anti-Thymocyte Immunoglobulins - Methods for producing improved anti-human thymocyte immunoglobulins from specific-pathogen-free animals are provided, without the need for an adsorption step on human tissues and the consequent drawbacks of such a step. | 2009-07-16 |
20090181044 | Novel Flavivirus antigens - The invention provides polynucleotides and polypeptides encoded therefrom having advantageous properties, including an ability to induce an immune response to flaviviruses. The polypeptides and polynucleotides of the invention are useful in methods of inducing immune response against flaviviruses, including dengue viruses. Compositions and methods for utilizing polynucleotides and polypeptides of the invention are also provided. | 2009-07-16 |
20090181045 | TAT-BASED VACCINE COMPOSITIONS AND METHODS OF MAKING AND USING SAME - A Tat-based vaccine composition comprising at least one antigen coupled to at least one immunostimulatory lentivirus trans-activator of transcription (Tat) molecule wherein the antigen is a cancer antigen an infectious disease antigen or a fragment thereof and methods to treat disease by administering the Tat-based vaccine composition. An additional Tat-based vaccine composition comprising immunostimulatory lentivirus Tat is provided. | 2009-07-16 |
20090181046 | Capsid Proteins and Uses Therefore - The present invention provides methods for the use of viral capsid proteins and chaperone proteins to produce immunogenic macro-molecular structures as antigen carrier to carry desired epitopes or antigens, for enhancing the immunogenicity of the carried epitopes or antigens for therapeutic or prophylactic vaccination. The immunogenic macro-molecular structures may also be used for therapeutic or prophylactic vaccination. | 2009-07-16 |
20090181047 | Anti-inflammatory hydrolysate of C. versicolor - Methods and compositions for reducing and/or inhibiting inflammation by topical application of dermatocosmetic compositions comprising effective amounts of extracts of | 2009-07-16 |
20090181048 | CANCER DRUG DELIVERY USING MODIFIED TRANSFERRIN - The present invention provides transferrin (Tf) conjugates of anti-cancer agents with increased cellular association and increased cellular internalization. The present invention also provides methods of treating cancer comprising administration of a Tf conjugate with increased cellular association to a subject with cancer. The present invention additionally provides methods of making, as well as screening for, Tf conjugates with increased cellular association or cellular internalization. The present invention also provides Tf conjugates with increased cellular association and internalization for delivering nucleic acids to cancer cells. | 2009-07-16 |
20090181049 | Capsular polysaccharide solubilisation and combination vaccines - Precipitated bacterial capsular polysaccharides can be efficiently re-solubilised using alcohols as solvents. The invention provides a process for purifying a bacterial capsular polysaccharide, comprising the steps of (a) precipitation of said polysaccharide, followed by (b) solubilisation of the precipitated polysaccharide using ethanol. CTAB can be used for step (a). The material obtained, preferably following hydrolysis and sizing, can be conjugated to a carrier protein and formulated as a vaccine. Also, in vaccines comprising saccharides from both serogroups A and C, the invention provides that the ratio (w/w) of MenA saccharide:MenC saccharide is >1. | 2009-07-16 |
20090181050 | Manufacturing Method of Combined Vaccine - The present invention relates to a method for manufacturing a combined vaccine capable of concurrently preventing multiple diseases such as diphtheria, tetanus, pertussis, and hepatitis B which should be prevented in an infant. The method for manufacturing a combined vaccine according to the present invention includes the steps of independently adsorbing each protective antigen to an adsorbent of a aluminum hydroxide gel with respect to various diseases such as diphtheria, tetanus, pertussis, and hepatitis B which should be prevented in the infants, and combining each protective antigen adsorbed to the adsorbent after the adsorption. In the present invention, it is possible to concurrently prevent multiple diseases such as diphtheria, tetanus, pertussis, and hepatitis B which should be prevented in the infant using a combined vaccine manufactured according to the present invention. | 2009-07-16 |
20090181051 | N-linked glycosylation alteration in E1 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine - E1, along with Erns and E2 is one of the three envelope glycoproteins of Classical Swine Fever Virus (CSFV). Our previous studies indicated that glycosylation status of either E2 or Erns strongly influence viral virulence in swine. Here, we have investigated the role of E1 glycosylation of highly virulent CSFV strain Brescia during infection in the natural host. The three putative glycosylation sites in E1 were modified by site directed mutagenesis of a CSFV Brescia infectious clone (BICv). A panel of virus mutants was obtained and used to investigate whether the removal of putative glycosylation sites in the E1 glycoprotein would affect viral virulence/pathogenesis in swine. We observed that rescue of viable virus was completely impaired by removal of all three putative glycosylation sites in E1. Single mutations of each of the E1 glycosylation sites showed that CSFV amino acid N594 (E1.N3 virus), as well the combined mutation of N500 and N513 (E1.N1N2 virus) resulted in BICv attenuation. Infection of either E1.N1N2 or E1.N3 viruses were able to efficiently protected swine from challenge with virulent BICv at 3 and 28 days post-infection. These results, along with those demonstrating the role of glycosylation of E | 2009-07-16 |
20090181052 | VACCINE - A method for prevention of HPV infection and/or disease, the method comprising delivery of a first HPV vaccine comprising an L1 protein or immunogenic fragment thereof from at least HPV 16 and HPV 18, and a second HPV vaccine which does not comprise the HPV 16 and HPV 18 L1 components from the first vaccine, and which second vaccine comprises an L1 protein or immunogenic fragment thereof from at least one other oncogenic HPV type, wherein the first and second vaccines may be delivered in either order and delivery is separated by a suitable time interval. | 2009-07-16 |
20090181083 | Porous tablets as carriers for liquid formulations - A novel tablet product that in an easy, flexible and reproducible manner can be loaded with a relatively high amount of a pharmaceutically acceptable liquid formulation e.g. carrying a therapeutically, prophylactically and/or diagnostically active substance. The novel loadable tablet product may be produced in large-scale batches and stored until use and each batch or sub-batch may be loaded with the same or different pharmaceutically acceptable liquid formulations and/or active substances. A loadable tablet according to the invention has a porosity of 30% v/v or more. The invention also provides tablets that have been loaded with such a liquid formulation as well as a method for the preparation thereof. | 2009-07-16 |
20090181084 | Oral fast-disintegrating tablet including particles of slowly-releaseable ascorbic acid - An oral fast-disintegrating tablet includes many tiny particles of slowly-releasable ascorbic acid, and a fast-disintegrating ingredient mixed with the many tiny particles that are dispersedly mixed with the fast-disintegrating ingredient. Each tiny particle is composed of a nucleus, an ascorbic layer and a release-control layer. The nucleus is coated with the ascorbic-acid layer and then with the releasing control layer to become a slowly-releasable particle. The tiny particles are mixed with the fast-disintegrating ingredient, which is composed of a mixture of ascorbic acid, water excipient, microcrystalline cellulose, a diluent agent, and disintegrant. So the tablet can be disintegrated swiftly in a mouth, and the tiny particles can enter the stomach and intestines with saliva to be slowly released, sustainingly absorbed by the organs. | 2009-07-16 |
20090181085 | UTILIZATION OF DIALKYLFUMARATES - The present invention relates to the use of certain dialkyl fumarates for the preparation of pharmaceutical preparations for use in transplantation medicine or for the therapy of autoimmune diseases and said compositions in the form of micro-tablets or pellets. For this purpose, the dialkyl fumarates may also be used in combination with conventional preparations used in transplantation medicine and immunosuppressive agents, especially cyclosporines. | 2009-07-16 |
20090181086 | Rasagiline formulations, their preparation and use - Disclosed are formulations which are designed to release rasagiline mesylate while maintaining specific pharmacokinetic properties. | 2009-07-16 |
20090181087 | Use of human cord blood-derived pluripotent cells for the treatment of disease - The present invention features methods of organ tissue regeneration using pluripotent cells derived from umbilical cord blood, compositions of these pluripotent cells, methods for further transforming these cells, and uses for these transformed cells. | 2009-07-16 |
20090181088 | THERMOSENSITIVE POLYPHOSPHAZENE-BIOACTIVE MOLECULE CONJUGATES, PREPARATION METHOD THEREOF AND USE THEREOF - The present invention relates to a poly(organophosphazene)-bioactive molecule conjugates in which biodegradable and thermosensitive poly(organophosphazene) with a functional group showing the sol-gel phase transition with change of temperature is combined with various bioactive molecules, such as drugs, a preparation method thereof, and a use thereof for delivery of bioactive molecules. | 2009-07-16 |
20090181089 | PH-Controlled Pulsatile Delivery System, Methods for Preparation and Use Thereof - The invention relates to delivery systems that allow for the pulsatile release of a substance, such as a drug, in response to a change in pH. More specifically, it relates to drug administration to the GI tract, in particular to site-specific intestinal drug delivery via the oral route. Provided is a pH-controlled pulsatile release system (PPRS) comprising a core surrounded by a coating layer, wherein said core comprises an active substance and wherein said coating layer comprises a pH-sensitive coating material wherein a swellable agent is embedded. Said swellable agent is capable of taking up at least 1.1 times, preferably at least 5 times, more preferably at least 10 times its weight in water. Also provided is a pharmaceutical composition comprising a PPRS, in particular a colon-specific PPRS. | 2009-07-16 |
20090181090 | Protein-Based Carrier System for Overcoming Resistance in Tumour Cells - Nanoparticles, the particle matrix of which is based on at least one protein and has at least one active agent embedded therein and methods of producing the nanoparticles with at least one active agent embedded in the protein matrix are disclosed. The use of the nanoparticles for the treatment of tumours, in particular for the treatment of tumours which are resistant to chemical medicaments is also disclosed. | 2009-07-16 |
20090181091 | PRODUCT AND PROCESS TO REGULATE A GENE NETWORK INVOLVED IN CONSTITUTIVE INFLAMMATION AND EARLY CANCER PROGRESSION - A recombinant construct arranged for expression of a specific hairpin microRNA which disrupts crosstalk between the two inflammatory pathways is described for intervening in early cancer progression events. Accordingly, the construct can be used as a molecular therapeutic approach to prevent cancer of epithelial origin in mammals, which include but are by no means limited to cancers of the head and neck, lung, breast, ovarian, and prostate tissues. | 2009-07-16 |
20090181092 | Methods for Treating Joints and Discs with a Carrier Matrix and Cells - Methods for enhancing pain relief and accelerating repair of painful disruptions associated with damaged and/or degenerated synovial joints and spinal discs are disclosed. These methods include injecting an effective amount of a biocompatible matrix or biocompatible polymeric compound, as well as a plurality of cells, into and/or around the damaged and/or degenerated synovial joints or spinal discs. The plurality of cells may include fibroblast cells, chondrocytes, genetically altered cells, stem cells such as mesenchymal stem cells, or combinations thereof. | 2009-07-16 |
20090181103 | CHOLESTEROL-LOWERING DAIRY PRODUCTS AND METHODS FOR THEIR PREPARATION - The invention relates to a concentrated or dried milk product having cholesterol-lowering effects and to methods for preparing the same. Provided is a process for the preparation of a milk concentrate or milk powder having a cholesterol-lowering effect, comprising :—preparing a milk liquid;—preparing a fat fraction comprising at least one sterol; and—subjecting the milk liquid to an evaporation procedure, during which procedure the fat fraction is added to the milk liquid before, in or after the liquid collector of one or more effects of the evaporator. Also provided is the product obtainable thereby. | 2009-07-16 |
20090181104 | BREAST RECONSTRUCTION OR AUGMENTATION USING COMPUTER-MODELED DEPOSITION OF PROCESSED ADIPOSE TISSUE - A tissue transfer method for reconstruction and augmentation of soft tissue. The method includes harvesting adipose tissue from a patient. The harvested tissue is processed via centrifugation to isolate a purified subset of the adipose tissue including separating and removing a substantial amount of triglycerides from the harvested adipose tissue. The centrifugation may be performed to cause separation of water from the purified adipose tissue and to cause separation of oil from mature adipocytes. Specifically, the spin rates may be selected to be high enough to cause lesions in the mature adipocytes that results in the release of the oil. The method continues with implanting the purified adipose tissue into the patient at a breast or other area identified for reconstruction or augmentation. The implanting is performed based on an injection pathway model that defines injection point locations and a number of injection pathway directions from each point. | 2009-07-16 |
20090181105 | METHOD OF ANTIOXIDATION, ANTIOXIDANT-FUNCTIONING WATER, AND USAGE OF THE SAME - The objective of the present invention is to provide an antioxidation method and antioxidant-functioning water that can anticipate high benchmarks of safety on the antioxidation subject such as the human body and reduced environmental burden. An antioxidation method and antioxidant-functioning water that can transform or maintain an antioxidation subject, which is in an oxidation state due to a deficiency of electrons or needs to be protected from oxidation, into a reduced state where electrons are filled by promoting the breaking reaction of molecular hydrogen used as a substrate included in the hydrogen-dissolved water into a product of active hydrogen through a process employing a catalyst, which is a precious metal colloid or a hydrogen oxidation/reduction enzyme (except for those already existing in a living organism), on the hydrogen-dissolved water. | 2009-07-16 |
20090181106 | COMPOSITIONS AND METHODS FOR TREATING VAGINAL INFECTIONS AND PATHOGENIC VAGINAL BIOFILMS - The present invention generally relates to methods and compositions for treating pathogenic vaginal biofilms. More specifically, the invention relates to pharmaceutical compositions comprising a combination of boric acid and diethylaminetetracetic acid (EDTA) and to methods of using such compositions to treat or prevent biofilm formation associated with vaginal infections, such as bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), trichomoniasis or mixed infections. | 2009-07-16 |
20090181107 | SOLUTION HAVING BIOCIDAL ACTIVITY - A method and apparatus for the electrochemical treatment of an aqueous solution in an electrolytic cell is described. Output solution having a predetermined level of available free chlorine is produced by applying a substantially constant current across the cell between an anode and a cathode while passing a substantially constant throughput of chloride ions through the cell. | 2009-07-16 |
20090181108 | Use of Bisphosphonates for Otosclerosis - A method of treating otosclerosis in a human in need thereof by administering a bisphosphonate in a defined dosing schedule. The invention demonstrates an effective response and sustained benefit in the treatment of otosclerosis. Particularly, the method involves administration of a bisphosphonate in a stepped-up dosage amount, e.g., in a dose that is at least one and a half times the recommended dose for osteoporosis. It also includes administration of a time-dependent dose of more than one bisphosphonate, specifically, alternating administration of a first bisphosphonate with a second bisphosphonate. The inventive method further includes intravenous administration of a bisphosphonate, and optionally oral administration of a bisphosphonate. The present invention further contemplates a kit for facilitating the alternating bisphosphonate dosing schedule | 2009-07-16 |
20090181109 | Nanoveson.TM.: treatment, biomarkers and diagnostic tests for liver diseases and comorbid diseases - A method of treatment of liver diseases and comorbid diseases is disclosed wherein an oral dose of lipids in an amount effective to trigger the release of cholecystokinin (CCK) into the duodenum to generate a major release of bile phospholipids from remodeled stores of triglycerides (TAG) in the liver, is administered to a patient in need thereof, thereby causing the formation of sequestered and aggregated mixed micelles and vesicles (SAMMVs) in the intestines of the patient which are then eliminated via the bowels of the patient. | 2009-07-16 |
20090181110 | Compositions from Garcinia as Aromatase Inhibitors for Breast Cancer Chemoprevention and Chemotherapy - Aromatase inhibitors (AIs) are disclosed which are useful in the treatment and prevention of post-menopausal breast cancer. New AIs derived from natural products are disclosed that are evaluated for clinical utility for treating post-menopausal breast cancer and may also act as chemopreventive agents for preventing breast cancer. Several pure compounds demonstrated AI activity using a noncellular, enzyme-based microsomal and a cell-based aromatase assay. Correlations are made between structural classes with levels of aromatase inhibition. The disclosure may be utilized to direct synthetic modification of natural product scaffolds to enhance aromatase inhibition or to standardize botanical dietary supplements for increased aromatase inhibition activity. | 2009-07-16 |
20090181111 | Saponin And Preservative Compositions For Reduction of Protozoa - The invention is related to methods and compositions for reducing protozoa populations in animals. In an embodiment, the invention includes a method for reducing protozoal populations including administering a first composition comprising an effective amount of saponins to the animal, and administering a second composition comprising an effective amount of a preservative to the animal. In an embodiment, the invention includes a method for killing protozoa comprising contacting protozoa with a composition comprising an effective amount of saponins and an effective amount of ethoxyquin. Other embodiments are included herein. | 2009-07-16 |
20090181112 | TABLET COMPOSITION CONTAINING KAMPO EXTRACT - Provided is a tablet composition containing Kampo extract having more excellent disintegration and dissolution properties than ever before. The tablet composition containing Kampo extract contains a Kampo extract powder, croscarmellose sodium, and sodium hydrogen carbonate. The Kampo extract powder is preferably at least one extract powder selected from the group consisting of Kakkonto, Kakkontokasenkyushin'i, Shoseiryuto, Tokishakuyakusan, Kamishoyosan, Keishibukuryogan, Hochuekkito, Bofutushosan, Goshajinkigan, Maobushisaishinto, Keishikajutsubuto, Juzentaihoto, Sokeikakketsuto, Shakuyakukanzoto, Keishininjinto, Tokakujokito, Yokukansan, Goreisan, and Eppikajutsuto. | 2009-07-16 |
20090181113 | Compositions for the reversal of stratum granulosum in keratinization disorders - Compositions that, when used topically in a therapeutically effective amount, are safe and effective for the regression of stratum granulosum in patients exhibiting keratinization disorders, such as psoriasis. The compositions, which can be formulated as ointments, oils, soaps and shampoos, comprise a non-aqueous extract of Wrightia tinctoria, an extract of Cocos nucifera, and pharmaceutically or cosmetically acceptable excipients suitable for topical use. | 2009-07-16 |
20090181114 | CHIA SEED BEVERAGE AND RELATED METHOD - A beverage is disclosed that is effective for enhancing gastrointestinal regularity and heart health. It is formed by a liquid comprising fruit derived juices, water or naturally or artificially flavored water. A composition of matter is mixed within the liquid in a shelf stable pasteurized beverage form and formed from sterilized whole seed extracted from | 2009-07-16 |
20090181115 | Method of Screening for Compounds That Alter Skin and/or Hair Pigmentation - The invention provides a method of identifying compounds that either increase or decrease skin and/or hair pigmentation, the method comprising determining the ability of a test compound to modulate NCKX-mediated calcium ion movement across a membrane (e.g. NCKX5). The method may comprise the steps of exposing a membrane comprising a NCKX molecule or variant, fusion or derivative thereof to a test compound and measuring either directly or indirectly the calcium ion concentration on one or both sides of the membrane. The invention also relates to kits, nucleic acid molecules, polypeptides and cells useful in the method of the invention. | 2009-07-16 |
20090181116 | AXMI-031, AXMI-039, AXMI-040 AND AXMI-049, A FAMILY OF NOVEL DELTA-ENDOTOXIN GENES AND METHODS FOR THEIR USE - Compositions and methods for conferring pesticidal activity to bacteria, plants, plant cells, tissues and seeds are provided. Compositions comprising a coding sequence for a delta-endotoxin polypeptide are provided. The coding sequences can be used in DNA constructs or expression cassettes for transformation and expression in plants and bacteria. Compositions also comprise transformed bacteria, plants, plant cells, tissues, and seeds. In particular, isolated delta-endotoxin nucleic acid molecules are provided. Additionally, amino acid sequences corresponding to the polynucleotides are encompassed, and antibodies specifically binding to those amino acid sequences. In particular, the present invention provides for isolated nucleic acid molecules comprising nucleotide sequences encoding the amino acid sequence shown in SEQ ID NO:2, 4, 6, 8, 10, 12, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, or 38, or the nucleotide sequence set forth in SEQ ID NO:1, 3, 5, 7, 9, 11, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, or 37, as well as variants and fragments thereof. | 2009-07-16 |
20090181117 | Containment System for Continuous Flow Hydrolizers - A material handling system for a hydrolyzer, comprising a material injection assembly further comprising a ram, a cylinder having a cylinder shaft for reciprocating the ram upon actuation of the cylinder shaft, a sleeve having an interior in which the ram reciprocates during use; a gate having a gate plate operable from between an open and a closed position; the gate plate has an aperture formed therethrough and the aperture is sized to enable a plug of compressed municipal solid waste to pass through it when the gate plate is in the open position; and a material exit assembly. The preferred material handling system further comprises a gate plate is interpositioned between the pair of space apart end plates and reciprocates freely therebetween. The end plates are configured to allow a plug of municipal solid waste to pass therethrough. The material exit assembly further comprises a processed material handling apparatus including a processed material compaction chamber; and a plunger assembly attached to the compaction chamber and further including a working cylinder having a cylinder shaft and a ram operably connected to the shaft enabling the ram to compact the processed material within the compaction chamber upon actuation of the cylinder and the extension of the shaft therefrom. | 2009-07-16 |
20090181118 | MULTIPLE ARTICLE INJECTION MOLDING SYSTEM - Principal components of injection molding apparatus include a U-frame, a carrier plate remotely affixable to the U-frame, preferably two cavity blocks remotely affixable to the carrier plate, a corresponding pair of core blocks, and a hot runner assembly remotely affixable to rear faces of the core blocks. These components are placed in a hydraulic press. In a molding operation, the U-frame, carrier plate and cavity blocks move as a unit relative to the hot runner assembly and the core blocks affixed thereto. To quickly change out one or both block pairs, a subassembly comprising the carrier plate and all core and cavity blocks is remotely released from the U-frame and the hot runner assembly and is removed as a unit. Face clamps in the front face of the carrier plate, the rear face of the cavity blocks, the rear face of the core blocks and the front face of the cavity blocks speed the changeout process and obviate potential damage to the molding geometry. A hot runner nozzle cap seat in each core block has a rear-facing bevel which receives a beveled hot runner nozzle cap tip. | 2009-07-16 |
20090181119 | Lateral core-pulling mechanism of mold - A lateral core-pulling mechanism of mold includes a cavity plate, a cavity insert configured in the cavity plate and defining a shaping recess, and a core-pulling body including a first slide module longitudinally movably disposed in the front of the cavity plate, an angular pin, and two second slide modules movably disposed at two sides of the cavity insert. The first slide module defines an inclined hole, a first shaping core inserted into the shaping recess and two first guide surfaces at two side edges thereof. The angular pin has an inclined block inclining forward and movably received in the inclined hole to drive the first slide module to move forward or backward. The second slide module defines a second shaping core inserted into the shaping recess and a second guide surface slidably matching the corresponding first guide surface to drive the second slide module to move sideward. | 2009-07-16 |
20090181120 | Injection Molding Apparatus Having Movable Yoke Plate - A coinjection molding apparatus includes a manifold, a nozzle body coupled to the manifold, a sleeve disposed within the nozzle body and defining an outer melt channel between the sleeve and the nozzle body, a pin disposed within the sleeve and defining an inner melt channel between the pin and the sleeve, and a nozzle tip having an alignment portion contacting the sleeve. The sleeve is actuated to open and close melt communication of the outer melt channel and a cavity gate. The pin is actuated to open and close melt communication of the inner melt channel and an opening of the sleeve. The alignment portion aligns the sleeve with the cavity gate along the actuated range of the sleeve. | 2009-07-16 |
20090181121 | Feedstuff and method for supply of gamma-aminobutyric acid - γ-Aminobutyric acid is supplied to animal efficiently and inexpensively to effectively enhance stress-relieving effect on the animal. | 2009-07-16 |
20090181122 | Method of producing bacterial polysaccharides in rumen fluid - A method of synthesizing rumen bacterial polysaccharides in increased amounts using a cow as the growth apparatus, a special formulation of normal cow feed as a substrate and a combination of feeding time, time of day, feeding technique, collection area within the rumen, feed physical form and number of feedings to maximize bacterial growth and diversity is described. The feeding of these bacterial polysaccharides the first few days of young animals' lives aids in decreasing diarrhea morbidity, severity and mortality. In addition it results in increased growth rate. | 2009-07-16 |
20090181133 | SPICE PACKAGING SYSTEM - A spice packaging system is provided that includes a plurality of packets for one or more spices, herbs or spice blends. Each packet includes a flexible packaging material that is impervious to light, gas and moisture. The packet has an exterior and a single or segmented enclosed and sealed interior space. A known volume of a single certified organic spice or herb is contained with the interior space of each packet, and an inert gas surrounds each known volume of the single certified organic spice or herb within the interior space. | 2009-07-16 |
20090181134 | KEEPSAKE CAKE KIT - A keepsake cake kit includes at least one of a cake mix for making a cake having a first predetermined size and a first predetermined shape, and a pre-made cake having a second predetermined size and a second predetermined shape. A base is provided for supporting at least one of such cake made from such cake mix and such pre-made cake. A covering member is releasably securable to such base for covering such base and such at least one of such cake made from such cake mix and such pre-made cake supported on such base. Edible decorations are included for decorating at least one of such cake made from such cake mix and such pre-made cake. At least one keepsake decoration which is disposable on such at least one of such cake made from such cake mix and such pre-made cake is also included in the kit. | 2009-07-16 |
20090181135 | Dough and dough product packaging configurations - Described are dough products that include a packaged refrigerator-stable, raw, dough compositions, and related methods, including but not limited to dough products that include a package having specific venting, specific opening mechanisms, and other specific package structures. | 2009-07-16 |
20090181136 | Method for Sealing a Package and a Package - The invention relates to a method for sealing a package ( | 2009-07-16 |
20090181137 | Frozen Confections Fortified with Calcium - The present invention provides frozen confections having an overrun of less than 30% and comprising by weight of the frozen confection: at least 0.2% calcium, at most 17% free sugars, and from 0.1 to 20% fat which contains less than 20% saturated fatty acids by weight of the fat; wherein at least 20% by weight of the calcium is present as part of a milk mineral composition. | 2009-07-16 |
20090181138 | PROCESS FOR PRODUCING PRECOOKED BACON SLICES - A process for producing precooked bacon slices comprising the steps of (a) conveying bacon slices through a spiral oven, (b) indirectly cooking the bacon slices in the spiral oven using a cooking medium which is circulated within the oven at a low rate sufficient to prevent the bacon slices from being displaced on the conveyor, and (c) adding steam to the cooking medium as necessary to at least reduce the percentage or substantially eliminate the presence of air in the cooking medium. | 2009-07-16 |
20090181139 | Pressure Assisted Thermal Sterilisation or Pasteurisation Method and Apparatus - The invention relates to a method suitable for pasteurisation or sterilisation of articles, and apparatus suitable for carrying out the method. The method includes heating the article and/or a related medium within a confined volume sufficiently that expansion of the article and/or the medium subjects the article to a pressure sufficient (in combination with the temperature) to result in pasteurisation or sterilisation of the article. | 2009-07-16 |
20090181140 | METHOD OF PREPARING EGG NUGGETS - A method that entails blending an egg-based substance, a water-absorbent thickener, and pieces of supplemental food together to form an egg-based material, the egg-based substance including a natural liquid egg component, the water-absorbent thickener distributed throughout the egg-based material, and the water-absorbent thickener effective to maintain distribution of the pieces of supplemental food throughout the egg-based material. | 2009-07-16 |
20090181141 | FLAVOUR RELEASE MATERIAL AND ITS USE IN DIFFERENT FOOD PRODUCTS - A flavour release material comprising a vegetable fibrous material with natural or artificial cavities and a solution comprising at least one lipophilic flavouring and at least one lipophilic component, such as an oil or a fat, is disclosed. The disclosed solution is applied to the cavities to provide controlled release of flavouring. A food product comprising the flavour release material and a method of producing the flavour release material are also disclosed. | 2009-07-16 |
20090181142 | MOLDABLE SUBSTANCES AND STRIPS FOR MAKING BAKED ITEMS WITH DESIRED SPATIAL FEATURES - Methods and systems provided herein relate to forming an item with desired spatial features. The item may be a food item, such as a baked item or a cake. The desired spatial features may include two-dimensional shapes and/or three-dimensional features. The item may be formed into the desired shape by forming a moldable substance and/or flexible strips. | 2009-07-16 |
20090181143 | Method of operating a beverage brewer - A beverage brewer ( | 2009-07-16 |
20090181144 | MAGNETIC AERATOR METHOD - A magnetic aerator includes a liquid agitating blade insertable into a hand held beverage container along with a magnet disposed at the blade with the magnet introducing a magnetic field into the liquid. A finger manipulatable stem supports the blade and enables manual agitation of the liquid by the blade approximate a surface of the liquid. | 2009-07-16 |
20090181145 | PROCESS FOR PREPARING AN AERATED FOOD PRODUCT COMPRISING PROTEIN AND FIBER - A process of making an aerated food product comprising protein and fiber is described. | 2009-07-16 |
20090181146 | MULTI-STAGE COOKING SYSTEM USING RADIANT, CONVECTION, AND MAGNETIC INDUCTION HEATING, AND HAVING A COMPRESSED AIR HEAT GUIDE - A cooking system for cooking foods using a combination of magnetic induction, convection and radiant heat, including a magnetic induction stage proximate the inlet end of a cooking chamber in which food is cooked by convention and radiant heating. A conveyor system, either continuous or configured in stages, passes food from the magnetic induction heating stage to and through the radiant and convention heating stages. | 2009-07-16 |
20090181147 | COMPOSITIONS AND RECIPES FOR GLUTEN-FREE BAKED PRODUCTS - Gluten-free vegan mixtures, compositions and recipes for baked goods with improved qualities including, but not limited to, taste, texture consistency and nutritional value. In one embodiment, a recipe for preparing a dry mix for gluten-free baked goods is provided. The recipe is comprised of approximately ½ part rice flour, ¼ part bean flour, ⅛ part tapioca starch, ⅛ part corn starch, 1/100 part baking powder, 3/500 part baking soda and 1/58 part any combination of guar, xanthan, locust bean gums and/or locust root. | 2009-07-16 |
20090181148 | SHELF-STABLE MILK CONCENTRATES FOR PREPARING ACIDIFIED MILK BASED BEVERAGES - A shelf-stable liquid base composition useful for preparing acidified milk based beverages, e.g. by dilution with water in a beverage dispensing machine, comprises: from about 2 to about 10 weight % of denatured milk proteins expressed as solid-not-fat (SNF) milk components; from about 15 to about 80 weight %, expressed as sugar equivalents, of a carbohydrate based or non carbohydrate based sweetener; from about 0.35 to about 1.50 weight % of a carbohydrate based stabilizer; and an acidifying agent present in amounts necessary for achieving a pH of about 3.0 to about 3.8 of the said base composition. Methods for preparing such a base composition and acidified milk based beverages prepared by means of such a base composition. | 2009-07-16 |
20090181149 | LOW SATURATED-FAT SUNFLOWER AND ASSOCIATED METHODS - Provided are sunflowers, parts thereof, cultures of, and seeds that are capable of producing sunflower oil that is low in saturated fat and, optionally, high in linoleic acid as well as associated methods. | 2009-07-16 |
20090181150 | Cholesterol lowering supplement and low cholesterol egg produced by using the same - This invention provides compositions and methods for producing low cholesterol poultry eggs using hypocholesterolemic compounds, cholesterol lowering supplements, and feeds therefrom. Preferably, this invention provides microbial statins without methyl group in C6, as shown in formula V, in order to produce low cholesterol poultry eggs. | 2009-07-16 |
20090181151 | Soybean Paste 2C and Method for Preparing Thereof - A set of invention relates to soy-bean based-food products and to methods for producing pastes and farces by grinding and heat-treating vegetable raw material. The inventive soy-bean paste 2C is embodied in the form of an aqueous suspension of fine natural soya beans, comprises, at a water/soya bean mass ratio equal to 1:(2-6), protein, fats, including polysaturated fatty acids, carbohydrates, vitamins and microelements and is characterised in that it exhibits a greater vitamin access rate in comparison with natural soya beans, in particular (in mg/100 g of soya beans) PP vitamin not less than 6.0 and B2 vitamin not less than 0.35, wherein the fat content, in which the quantity of polysaturated fatty acids ranges from 55 to 62 mass %, corresponds to the soya bean fat content. The inventive method for producing the 2C paste is based on a hydrodynamic action produced on beans in a liquid by forcedly circulating components through a closed reservoire-pump-nozzle-reservoire circuit associated with degassing and consists in turbulating and cavitating a medium in such a way that a hot suspension is obtained, wherein the circulation is carried out during 240-280 cycles until a paste is formed, degassing is carried out for 1-10 seconds after the exposure of the beans to the hydrodynamic action by depressurising a mixer, whose free volume is filled with the liquid, in holding the mixture heated to a temperature of 100-112° C. for 5-30 minutes and in discharging said mixture for packing or in cooling it. | 2009-07-16 |
20090181152 | Low fat meat compositions capable of high temperature cooking - Meat compositions are provided that have the capability to successfully char-cook at high temperatures of 700 degrees Fahrenheit and above, consisting of meat, water, textured protein concentrate, water binders, a fat binder/emulsifier/dispersion agent, and salt. The preferred embodiments reproduce the mouth-feel and taste of 100% meat. The invention makes possible high temperature cooking at lower fat content, which is not possible with meats containing less than 19% fat. The preferred embodiment reduces the percentage of fat to a range of 9-11.25%, plus a negligible amount of fat from the non-meat ingredients, and this compares very favorably to 22% fat content stated as the optimum requirement, by the Nieco Company, manufacturer of high temperature broilers. The benefits of the invention are reduced fat content as a dietary consideration, food that is easier to digest, substantial reduction of greenhouse gases, particulate matter and volatile organic compounds caused by char-cooking of meats containing higher fat content, and less overall need for animal meat, which translates into reduced greenhouse gases cause by live animals. The invention contributes to worldwide efforts to reduce global warming. | 2009-07-16 |
20090181153 | Dry-Mill Ethanol Plant Extraction Enhancement - In a liquid stream capture process for extracting various components in a dry mill ethanol process, a converted mash is separated into sugars/carbohydrates and corn residue by rinsing the converted mash with a dilute solvent stream and, after the sugars/carbohydrates have been separated, oils and proteins are extracted from the corn residue by rinsing the corn residue with a concentrated solvent stream. The dilute solvent stream is a mixture of ethanol and water, and the concentrated solvent stream is pure ethanol. | 2009-07-16 |
20090181154 | NON-ALLERGENIC INGREDIENTS AND FOOD PRODUCTS - The present invention relates to a non-allergenic food product, comprising an amino acid fraction comprising at least one component selected from the group consisting of amino acids and peptides having a degree of polymerization of 7 or less; and a lipid fraction comprising at least one fatty acid selected from the group consisting of arachidonic acid and docosahexanoic acid, the composition having a content of proteins and other peptides having a molecular weight of 1000 dalton or more of less than 0.01 wt. %, based on the dry weight, preferably less than 0.001 wt. %, more preferably less than 0.0001 wt %. | 2009-07-16 |
20090181155 | Kebab machine carrier - A kebab machine ( | 2009-07-16 |
20090181156 | MARKED PRECOATED MEDICAL DEVICE AND METHOD OF MANUFACTURING SAME - A method of manufacturing a coated medical device, such as a medical guide wire, including at least applying a first colored coating to at least a first portion of an outer surface of a medical guide wire, securing a first end of the medical guide wire, and for each a designated quantity of turns, turn a second end of the medical guide wire upon a longitudinal axis of the medical guide wire. The method of manufacturing also includes securing the second end of the medical guide wire, blocking at least a first portion of the coated surface of the medical guide wire, applying a second contrasting colored coating to at least a second, unblocked portion of the outer surface of the medical guide wire and releasing the first end and the second end of the medical guide wire to display at least one spiral marking formed along a length of the medical guide wire. | 2009-07-16 |